✦ LIBER ✦

Randomized Phase II evaluation of iproplatin (CHIP) and carboplatin (CBDCA) in lung cancer. A Southeastern Cancer Study Group trial

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II evaluation of ipropl

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Carboplatin (CBDCA) plus alpha interfero

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Phase I–II trial of carboplatin (CBDCA)

✍ Massutí, B.; Barneto, I.; Meana, J.A.; Herrero, J.; Picó, C.; Aranda, E.; García 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Phase I trial of carboplatin-cyclophosph

✍ Alberts, David; Mason, Nancy; Surwit, Earl; Weiner, Sheldon; Hammond, Neel; Depp 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Carboplatin (CBDCA), ifosfamide (IFX) an

✍ Candamio, S.; Menéndez, M.D.; Irigoyen, A.; Barón, F.J.; Vázquez, F.; Cueva, J.F 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A phase-II trial of carboplatin (CBDCA)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB